Frontiers in Hematology

Original Research

Published on 26 Dec 2024

Unique target binding by the C-terminal region of FHR1 provides a new perception of aHUS pathology

in Immunobiology and Immunotherapy

Luce Perie
Selina Stippa
Christoph Saffer
Andrea Hartmann
Mathias Mörgelin
Svante L. H. Zipfel
Marc Thilo Figge
Thorsten Wiech
Christine Skerka
Peter F. Zipfel

Frontiers in Hematology

doi 10.3389/frhem.2024.1469176

1,007 views
2 citations

Mini Review

Published on 24 Dec 2024

Leveraging big data and artificial intelligence for smarter trials in myeloproliferative neoplasms

in Blood Cancer

Joshua W. Bliss
Spencer Krichevsky
Joseph Scandura
Ghaith Abu-Zeinah

Frontiers in Hematology

doi 10.3389/frhem.2024.1504327

967 views

Case Report

Published on 17 Dec 2024

A patient with concurrent EBV-negative diffuse large B-cell lymphoma and angioimmunoblastic T-cell lymphoma: a case report

in Blood Cancer

Monika A. Satoskar
Matthew R. Lordo
Daniel M. Jones
Nicholas B. Nowacki
Jonathan E. Brammer
John C. Reneau
Timothy J. Voorhees

Frontiers in Hematology

doi 10.3389/frhem.2024.1463487

770 views

Case Report

Published on 12 Dec 2024

Ruxolitinib and pegylated interferon in Chronic Neutrophilic Leukemia due to a pathogenic CSF3R germline variant: a case report

in Blood Cancer

Selene Grano
Valentina Bonuomo
Diana Carli
Veronica Peri
Loredana Farinasso
Ugo Ramenghi
Daniela Cilloni
Carmen Fava

Frontiers in Hematology

doi 10.3389/frhem.2024.1508463

530 views

Case Report

Published on 09 Dec 2024

Case report: Vitamin B12 deficiency-associated hemolytic anemia

in Red Cells, Iron and Erythropoiesis

Chiranjeevi Sainatham
Paul Stendahl Dy
Sharanya Kaushik
Jayanth Reddy Tallapalli
Viral Patel
Vishal Jindal
Sonal Paul

Frontiers in Hematology

doi 10.3389/frhem.2024.1446241

2,902 views
1 citation

Study Protocol

Published on 06 Dec 2024

Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)

in Blood Cancer

Theo Leitner
Evgenii Shumilov
Christina Schwitlick
Raphael Koch
Franziska Hamm
Marion Högner
Florian Bassermann
Katja Weisel
Hermann Einsele
Martin Kortüm

Frontiers in Hematology

doi 10.3389/frhem.2024.1436845

1,117 views

Original Research

Published on 05 Dec 2024

Prevalence of measurable residual disease in patients with refractory/relapsed multiple myeloma who reached complete response: a cross-sectional multicentric study

in Blood Cancer

Manuel Neves
Rita Gerivaz
Graça Esteves
Rui Bergantim
Gisela Ferreira
Henrique Coelho
Celina Afonso
Delfim Duarte
Anabela Neves
Helena Matos Silva

Frontiers in Hematology

doi 10.3389/frhem.2024.1480120

807 views

Review

Published on 03 Dec 2024

Delineation of erythropoietic intermediates by flow cytometry

in Red Cells, Iron and Erythropoiesis

Kathleen E. McGrath

Frontiers in Hematology

doi 10.3389/frhem.2024.1496916

1,249 views

Original Research

Published on 02 Dec 2024

Rare cell-based liquid biopsy for improved measurement of low-grade chronic inflammation

in Red Cells, Iron and Erythropoiesis

Stefan Schreier
Prapaphan Budchart
Suparerk Borwornpinyo
Panuwat Lertsithichai
Wannapong Triampo

Frontiers in Hematology

doi 10.3389/frhem.2024.1472609

579 views

Original Research

Published on 26 Nov 2024

Exploring the regenerative capacity of the spleen following irradiation

in Hematopoiesis and Stem Cells

Christie T. M. Short
Helen C. O’Neill
Jonathan K. H. Tan

Frontiers in Hematology

doi 10.3389/frhem.2024.1396672

775 views

Original Research

Published on 22 Nov 2024

Distinct clinico-genomic factors drive outcomes in patients with myelofibrosis and disease-related anemia

in Blood Cancer

Somedeb Ball
Najla H. Al Ali
Akriti G. Jain
Luis E. Aguirre
Seongseok Yun
Onyee Chan
Zhuoer Xie
David A. Sallman
Jeffrey Lancet
Eric Padron

Frontiers in Hematology

doi 10.3389/frhem.2024.1492680

600 views

Case Report

Published on 15 Nov 2024

Late onset pancytopenia post chimeric antigen receptor T cell therapy triggered by a COVID-19 vaccination: a case report

in Hematopoiesis and Stem Cells

Nicola Maciocia
Dean Spencer
Paul Maciocia
Anna Childerhouse
Maeve O’Reilly
Elspeth Payne
Claire Roddie

Frontiers in Hematology

doi 10.3389/frhem.2024.1435584

896 views

Case Report

Published on 13 Nov 2024

Case report: VEXAS syndrome and literature review

in Blood Cancer

Can Jones
Stanislav Ivanov
Pablo Ferraro
Souhad Younes
Hugo Fernandez

Frontiers in Hematology

doi 10.3389/frhem.2024.1480436

1,054 views
1 citation

Review

Published on 29 Oct 2024

Early T-cell precursor acute lymphoblastic leukemia: diagnostic pitfalls, genomic alteration, novel therapeutics, and minimal residual disease monitoring

in Blood Cancer

Binsah George
Kok Hoe Chan
Adan Rios

Frontiers in Hematology

doi 10.3389/frhem.2024.1463410

3,215 views
1 citation

Editorial

Published on 18 Oct 2024

Editorial: Editors’ showcase: red cells, iron and erythropoiesis

in Red Cells, Iron and Erythropoiesis

Anna Rita Migliaccio

Frontiers in Hematology

doi 10.3389/frhem.2024.1457513

490 views

Perspective

Published on 18 Oct 2024

The CHIP-clinic as the catalyst of preventive medicine

in Blood Cancer

Hans Carl Hasselbalch
Vibe Skov
Lasse Kjaer
Trine Alma Knudsen
Christina Schjellerup Eickhardt-Dalbøge
Christina Ellervik
Sabrina Cordua
Anders Lindholm Sørensen
Sarah Friis Christensen
Marie Hvelplund Kristiansen

Frontiers in Hematology

doi 10.3389/frhem.2024.1459154

1,448 views
1 citation